Stephen Pollitt

President

2010 - Current

Board Director

2010 - 2014

Drug Development Project Management Consulting

2007 - 2010

Help clients develop and manage project teams working on early stage drug development projects. Assist with planning of scope, timing and resources to reach critical milestones. Strategic assessment of risk and risk mitigation planning. Scientific assessment of drug target, disease indication, pharmacology and toxicology data. Clients have ranged from virtual start ups to public companies.

Director/Project Team Leader

2003 - 2007

Project Team Leader for early stage biologic transitioning into the clinic with overall responsibility for establishment of project strategy and leadership of Compound Development Team in the area of Maternal-Fetal Medicine.

Staff Scientist/Assoc Director

1990 - 2003

Research project leader for small molecule drug discovery projects. Served on team charged with evaluation of new drug targets based on scientific rationale, clinical and regulatory feasibility, market size and portfolio considerations. Head of protein expression/protein chemistry laboratory. Responsible for development of cell lines for manufacturing of recombinant proteins for clinical testing as well as testing of small molecule drug candidates.

Scientist

1989 - 1990

Founded and led team responsible for engineering of host cell lines for recombinant production of biologics destined for clinical testing.